CORCEPT THERAPEUTICS INC (CORT) has 26 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 6 sales totalling $15.6M. Most recent filing: Sept. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 18, 2026 filed Sept. 16, 2026 | Vieira Roberto Wandenkolk President, Oncology | −$29,843 | 296 | −7% | Yes | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 17, 2026 | Robb Gary Charles Chief Business Officer | $144,667 | 34,986 | +11% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Maduck Sean See Remarks | $2,653,987 | 75,417 | +2% | Yes | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Guyer William Chief Development Officer | $18,594 | 328 | +8% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Mokari Atabak Chief Financial Officer | — | +174 | +1% | No | |
|
|
||||||
Showing the 5 most recent of 26 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free